Our analysis identified 4 key inflammatory factors (CCL25, M-CSF1, IL-33, and FGF21) causally associated with GBM risk, with M-CSF1 showing the strongest promoting effect and FGF21 exhibiting significant protective properties. The gene discussed is CCL25; the disease is glioblastoma.